The Pharmacokinetics of Colistin in Patients with Cystic Fibrosis
- 1 June 2001
- journal article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 41 (6), 645-654
- https://doi.org/10.1177/00912700122010537
Abstract
The safety and pharmacokinetics ofcolistin were determined after first dose (n = 30) and again under steady‐state conditions (n = 27) in 31 patients with cystic fibrosis receiving the drug as a compo...Keywords
This publication has 31 references indexed in Scilit:
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Effect of tonicity of nebulised colistin on chest tightness and pulmonary function in adults with cystic fibrosisThorax, 1997
- Effect of High-Dose Ibuprofen in Patients with Cystic FibrosisNew England Journal of Medicine, 1995
- Antibiotic Therapy for Chronic Infection of Pseudomonas in the LungAnnual Review of Medicine, 1993
- Emergence of antibiotic resistance amongst Pseudomonas aeruginosa isolates from patients with cystic fibrosisJournal of Antimicrobial Chemotherapy, 1993
- Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatmentThe Lancet, 1991
- Colistin inhalation therapy in cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infectionJournal of Antimicrobial Chemotherapy, 1987
- Bioactivity of Gentamicin in Purulent Sputum from Patients with Cystic Fibrosis or Bronchiectasis: Comparison with Activity in SerumThe Journal of Infectious Diseases, 1983
- Binding of Polymyxin Antibiotics to Tissues: The Major Determinant of Distribution and Persistence in the BodyThe Journal of Infectious Diseases, 1971